Care programme for prospective parents with an infectious disease

The CRG of UZ Brussel has a worldwide reputation for its expertise in Assisted Reproductive Treatment (ART) and all related treatments.
In our work, patient care is key and over the years we have always paid a great deal of attention to improving – in terms of comfort and effectiveness – our treatments.

Based on this philosophy, we have developed an appropriate treatment plan (or care programme) for prospective parents with an infectious disease.
Whether you are a man or a woman who is infected, or perhaps you are both infected, it is possible to bring a healthy child into the world.

Practical organisation of an ART treatment in an infectious care pathway

If you have an infectious disease and wish to have a child, you can contact the CRG for a first appointment with the doctor. See 12.5 contact.
You may also send your request by e-mail to infcrg@uzbrussel.b
  • As soon as we - you and the CRG - have been informed of the presence of an infectious disease, the fertility doctor at the CRG will assess your file.
    If necessary, this may also be performed by the specialist at UZ Brussel (infectious diseases or hepatology departments).
    Further tests may be necessary.
    After approval of your request by UZ Brussel, your ART treatment at the CRG can start.
  • If the infectious disease comes to light during the preliminary tests for fertility treatment, we will first refer you to an infectious diseases specialist for further diagnostic examination.
    If you have an HIV infection, you will also be seen by a psychologist at the CRG and your file will be submitted to a multidisciplinary consultative committee.
  • Further treatment and monitoring of the infectious disease is possible both at UZ Brussel or another medical institute.
    Decisions regarding your fertility treatment – whether or not you are eligible – are made by UZ Brussel.
  • As prospective parent(s) with an infectious disease accepted for an ART treatment at the CRG, your treatment will be similar, broadly speaking, to that of all uninfected prospective parents. See artificial insemination and IVF-ICSI (among others).